Interaction between fluids and vasoactive agents on mortality in septic shock: A multicenter, observational study

Critical Care Medicine

Volumn 42, Issue 10, 2014, Pages 2158-2168

  Waechter, Jason ^a   Kumar, Anand ^b   Lapinsky, Stephen E ^c   Marshall, John ^c   Dodek, Peter ^d   Arabi, Yaseen ^e   Parrillo, Joseph E ^f   Phillip Dellinger, R ^g   Garland, Allan ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^f HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^g Department of Medicine Cooper Medical School of Rowan University ^*  (United States)

Author keywords

Resuscitation; Septic shock; Statistical models; Vasoactive agonists

Indexed keywords

INFUSION FLUID; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SEPTIC SHOCK; ADOLESCENT; AGED; CLINICAL TRIAL; FLUID THERAPY; MIDDLE AGED; PROCEDURES; SHOCK, SEPTIC; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84914097584     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000520     Document Type: Article

References (32)

1. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classifcation system. Crit Care Med 1985; 13:818-829
2. Annane D, Aegerter P, Jars-Guincestre MC, et al; CUB-Réa Network: Current epidemiology of septic shock: The CUB-Réa Network. Am J Respir Crit Care Med 2003; 168:165-172
3. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
4. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377
5. Jones AE, Brown MD, Trzeciak S, et al; Emergency Medicine Shock Research Network investigators: The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: A meta-analysis. Crit Care Med 2008; 36:2734-2739
6. Jansen TC, van Bommel J, Schoonderbeek FJ, et al; LACTATE study group: Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182:752-761
7. Zanotti-Cavazzoni SL, Guglielmi M, Parrillo JE, et al: Fluid resuscitation infuences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med 2009; 35:748-754
8. McIntyre LA, Fergusson D, Cook DJ, et al; Canadian Critical Care Trials Group: Resuscitating patients with early severe sepsis: A Canadian multicentre observational study. Can J Anaesth 2007; 54:790-798
9. Maitland K, Kiguli S, Opoka RO, et al; FEAST Trial Group: Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
10. Chappell D, Jacob M, Hofmann-Kiefer K, et al: A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-740
11. American Thoracic Society: Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 2004; 170:1247-1259
12. Myburgh JA, Finfer S, Bellomo R, et al; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911
13. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887
14. Sakr Y, Reinhart K, Vincent JL, et al: Does dopamine administration in shock infuence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34:589-597
15. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
16. Dünser MW, Ruokonen E, Pettilä V, et al: Association of arterial blood pressure and vasopressor load with septic shock mortality: A post hoc analysis of a multicenter trial. Crit Care 2009; 13:R181
17. Beale RJ, Hollenberg SM, Vincent J-L, et al: Vasopressor and inotropic support in septic shock: An evidence-based review. Crit Care Med 2004; 32(11 Suppl):S455-S465
18. Hollenberg SM: Vasopressor support in septic shock. Chest 2007; 132:1678-1687
19. Bagshaw SM, Lapinsky S, Dial S, et al; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009; 35:871-881
20. Kumar A, Ellis P, Arabi Y, et al; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group: Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136:1237-1248
21. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
22. Zarychanski R, Doucette S, Fergusson D, et al: Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med 2008; 36:2973-2979
23. Bone RC, Balk RA, Cerra FB, et al: Defnitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
24. Zhou Z, Rahme E, Abrahamowicz M, et al: Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: A comparison of methods. Am J Epidemiol 2005; 162:1016-1023
25. Hardin J, Hilbe J: General Estimating Equations. Boca Raton, Chapman & Hall/CRC, 2003
26. Husain FA, Martin MJ, Mullenix PS, et al: Serum lactate and base defcit as predictors of mortality and morbidity. Am J Surg 2003; 185:485-491
27. Marrie RA, Dawson NV, Garland A: Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. J Clin Epidemiol 2009; 62:511.e1-517.e1
28. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 2001; 15:364-376
29. Sennoun N, Montemont C, Gibot S, et al: Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med2007; 35:1736-1740
30. Sadaka F, Juarez M, Naydenov S, et al: Fluid resuscitation in septic shock: The effect of increasing fluid balance on mortality. J Intensive Care Med 2013 Feb 27 [Epub ahead of print]
31. Boyd JH, Forbes J, Nakada TA, et al: Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39:259-265
32. Marshall JC: Sepsis research: Where have we gone wrong? Crit Care Resusc 2006; 8:241-243